Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Cannabis Research|June 20, 2024
Non-linear plasma protein binding of cannabidiolMariana Babayeva, Iva Srdanovic
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|September 9, 2021
Factors Influencing 1st and 2nd Generation Drug-Eluting Stent Performance: Understanding the Basic Pharmaceutical Drug-in-Polymer Formulation Factors Contributing to Stent Thrombosis Do We Really Need to Eliminate the Polymer?Iva Srdanovic
Pharmacogenomics and Personalized Medicine|October 30, 2020
Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and HydroxychloroquineMariana Babayeva, Zvi Loewy
Current Issues in Molecular Biology|May 15, 2023
Cannabis Pharmacogenomics: A Path to Personalized MedicineMariana Babayeva, Zvi G Loewy
Methods in Molecular Biology (Clifton, N.J.)|September 6, 2022
COVID-19 Pharmacotherapy: Drug Development, Repurposing of Drugs, and the Role of PharmacogenomicsRebecca Bock, Mariana Babayeva, Zvi G Loewy
Methods in Molecular Biology (Clifton, N.J.)|September 6, 2022
Pharmacogenomics Informs Cardiovascular PharmacotherapyMariana Babayeva, Brigitte Azzi, Zvi G Loewy
Frontiers in Bioscience (Elite Edition)|March 23, 2022
Autism and associated disorders: cannabis as a potential therapyMariana Babayeva, Haregewein Assefa, Paramita Basu, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 24, 2006
Effects of trimethoprim on the clearance of apricitabine, a deoxycytidine analog reverse transcriptase inhibitor, and Lamivudine in the isolated perfused rat kidneyTomoko Nakatani-Freshwater, Mariana Babayeva, Aruna Dontabhaktuni, et al.
Parkinson'S Disease|January 5, 2017
Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease TherapyMariana Babayeva, Haregewein Assefa, Paramita Basu, et al.
The Journal of Pharmacy and Pharmacology|June 7, 2013
Determination of intestinal permeability of rigosertib (ON 01910.Na, Estybon): correlation with systemic exposureMichael P White, Mariana Babayeva, David R Taft, et al.
Pageof 2